Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients.
Journal: Biomarkers in medicine
Published: July 05, 2022
A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6.
Journal: Hepatology (Baltimore, Md.)
Published: February 22, 2018
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.
Journal: The Journal of infectious diseases
Published: February 08, 2018
Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis.
Journal: Hepatology (Baltimore, Md.)
Published: September 20, 2017
IFN-free therapy is associated with restoration of type I IFN response in HIV-1 patients with acute HCV infection who achieve SVR.
Journal: Journal of viral hepatitis
Published: July 26, 2017
Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types.
Journal: Hepatology (Baltimore, Md.)
Published: March 08, 2016
Showing 1-6 of 6
Last Updated: 09/26/2026